Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester

被引:7
|
作者
Gilham, Clare [1 ]
Sargent, Alexandra [2 ]
Crosbie, Emma J. [3 ,4 ]
Peto, Julian [1 ]
机构
[1] London Sch Hyg & Trop Med, London, England
[2] Manchester Univ NHS Fdn Trust, Manchester Royal Infirm, Cytol Dept, Manchester, Lancs, England
[3] Manchester Univ NHS Fdn Trust, Div Gynaecol, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[4] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
关键词
SEXUAL-BEHAVIOR; PREVENTION; CYTOLOGY;
D O I
10.1038/s41416-023-02227-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Long-term follow-up of large cohorts is needed to determine the effects of HPV and screening on CIN3 (grade 3 cervical intraepithelial neoplasia) and ICC (invasive cervical cancer). METHODS: Women were recruited when attending for routine cervical screening in Greater Manchester, UK: 1987-93 for the Manchester Cohort (MC: 47,625 women) and 2001-03 for the ARTISTIC Cohort (AC: 24,496 women). Both were followed through national registration for cancer incidence and mortality to 2020. RESULTS: Risk patterns following HPV infection differed for CIN3 and ICC. Risk of ICC in the MC rises for 30 years following a single positive HPV test, reaching 2.5% (95% CI: 1.3-4.5%). A similar pattern was seen in the AC, but the risks of cancer were approximately halved. CIN3 was diagnosed much sooner in the AC due to more efficient cytology. More sensitive HPV testing was able to better predict future risk. CONCLUSION: The sensitivity of HPV testing and cytology influences the CIN3 detection rate. Sensitive HPV testing enables effective risk stratification. Increased risk of ICC is observed 15-30 years after HPV infection. Women testing HPV + should be followed until their infection clears. Discharging women from screening programmes whilst they remain HPV + may not be safe, even if cytology and colposcopy tests are normal.
引用
收藏
页码:1933 / 1940
页数:8
相关论文
共 50 条
  • [1] Similar effectiveness with primary HPV and cytology screening - Long-term follow-up of randomized cervical cancer screening trial
    Vahteristo, Maija
    Leinonen, Maarit K.
    Sarkeala, Tytti
    Anttila, Ahti
    Heinaevaara, Sirpa
    GYNECOLOGIC ONCOLOGY, 2024, 180 : 146 - 151
  • [2] Clinically validated HPV assays offer comparable long-term safety in primary cervical cancer screening: A 9-year follow-up of a population-based screening cohort
    Valencak, Anja Ostrbenk
    Kroon, Kelsi R.
    Fabjan, Danijela
    Mlakar, Jana
    Seme, Katja
    Berkhof, Johannes
    Poljak, Mario
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (04) : 788 - 801
  • [3] Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial
    Smelov, Vitaly
    Elfstrom, K. Miriam
    Johansson, Anna L. V.
    Eklund, Carina
    Naucler, Pontus
    Arnheim-Dahlstrom, Lisen
    Dillner, Joakim
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : 1171 - 1180
  • [4] Long-term follow-up of cervical cancer incidence after normal cytological findings
    Wang, Jiangrong
    Edvardsson, Henrik
    Strander, Bjorn
    Andrae, Bengt
    Sparen, Par
    Dillner, Joakim
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (03) : 448 - 453
  • [5] Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial
    Vahteristo, Maija
    Leinonen, Maarit K.
    Sarkeala, Tytti
    Anttila, Ahti
    Heinavaara, Sirpa
    PREVENTIVE MEDICINE, 2024, 185
  • [6] HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome
    Wang, Xinmei
    Shuai, Guangnan
    Xu, Junhui
    Liu, Meihua
    Zhao, Jianguo
    Zhang, Na
    Zhang, Wenwen
    Qu, Pengpeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial
    Senore, Carlo
    Riggi, Emilia
    Armaroli, Paola
    Bonelli, Luigina
    Sciallero, Stefania
    Zappa, Marco
    Arrigoni, Arrigo
    Casella, Claudia
    Crosta, Cristiano
    Falcini, Fabio
    Ferrero, Franco
    Fracchia, Mario
    Giuliani, Orietta
    Risio, Mauro
    Russo, Antonio G.
    Visioli, Carmen Beatriz
    Rosso, Stefano
    Segnan, Nereo
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 36 - +
  • [8] Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
    D Mesher
    A Szarewski
    L Cadman
    H Cubie
    H Kitchener
    D Luesley
    U Menon
    G Hulman
    M Desai
    L Ho
    G Terry
    A Williams
    P Sasieni
    J Cuzick
    British Journal of Cancer, 2010, 102 : 1405 - 1410
  • [9] Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
    Mesher, D.
    Szarewski, A.
    Cadman, L.
    Cubie, H.
    Kitchener, H.
    Luesley, D.
    Menon, U.
    Hulman, G.
    Desai, M.
    Ho, L.
    Terry, G.
    Williams, A.
    Sasieni, P.
    Cuzick, J.
    BRITISH JOURNAL OF CANCER, 2010, 102 (09) : 1405 - 1410
  • [10] Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology - results from the Hammersmith study
    Cuzick, Jack
    Szarewski, Anne
    Mesher, David
    Cadman, Louise
    Austin, Janet
    Perryman, Karen
    Ho, Linda
    Terry, George
    Sasieni, Peter
    Dina, Roberto
    Soutter, William P.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2294 - 2300